Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asfar S Azmi

Showing results (1-10 of 154) with videos related to

Pageof 16
Sort By:
Current Drug Discovery Technologies|December 15, 2012
Adopting network pharmacology for cancer drug discoveryAsfar S Azmi
Current Cancer Drug Targets|October 31, 2013
Unveiling the role of nuclear transport in epithelial-to-mesenchymal transitionAsfar S Azmi
Journal of Cellular Physiology|September 4, 2008
Non-peptidic small molecule inhibitors against Bcl-2 for cancer therapyAsfar S Azmi, Ramzi M Mohammad
Future Medicinal Chemistry|March 22, 2014
Rectifying cancer drug discovery through network pharmacologyAsfar S Azmi, Ramzi M Mohammad
FEBS Letters|June 30, 2006
Prior exposure to restraint stress enhances 7,12-dimethylbenz(a)anthracene (DMBA) induced DNA damage in ratsIrfana Muqbil, Asfar S Azmi, Naheed Banu
Seminars in Cancer Biology|August 8, 2022
Deregulated transcription factors and poor clinical outcomes in cancer patientsYiwei Li, Asfar S Azmi, Ramzi M Mohammad
Leukemia|January 29, 2022
Selective inhibition of nuclear export: a promising approach in the shifting treatment paradigms for hematological neoplasmsSuresh Kumar Balasubramanian, Asfar S Azmi, Jaroslaw Maciejewski
Wiley Interdisciplinary Reviews. RNA|May 17, 2021
microRNA-based diagnostic and therapeutic applications in cancer medicineLorenzo F Sempere, Asfar S Azmi, Anna Moore
Cancers|July 16, 2011
Small molecule inhibitors of bcl-2 family proteins for pancreatic cancer therapyAshiq Masood, Asfar S Azmi, Ramzi M Mohammad
Cancer Metastasis Reviews|May 28, 2013
Exosomes in cancer development, metastasis, and drug resistance: a comprehensive reviewAsfar S Azmi, Bin Bao, Fazlul H Sarkar
Pageof 16

Showing results (1-10 of 154) with videos related to

Sort By:
Pageof 16
Current Drug Discovery Technologies|December 15, 2012
Adopting network pharmacology for cancer drug discoveryAsfar S Azmi
Current Cancer Drug Targets|October 31, 2013
Unveiling the role of nuclear transport in epithelial-to-mesenchymal transitionAsfar S Azmi
Journal of Cellular Physiology|September 4, 2008
Non-peptidic small molecule inhibitors against Bcl-2 for cancer therapyAsfar S Azmi, Ramzi M Mohammad
Future Medicinal Chemistry|March 22, 2014
Rectifying cancer drug discovery through network pharmacologyAsfar S Azmi, Ramzi M Mohammad
FEBS Letters|June 30, 2006
Prior exposure to restraint stress enhances 7,12-dimethylbenz(a)anthracene (DMBA) induced DNA damage in ratsIrfana Muqbil, Asfar S Azmi, Naheed Banu
Seminars in Cancer Biology|August 8, 2022
Deregulated transcription factors and poor clinical outcomes in cancer patientsYiwei Li, Asfar S Azmi, Ramzi M Mohammad
Leukemia|January 29, 2022
Selective inhibition of nuclear export: a promising approach in the shifting treatment paradigms for hematological neoplasmsSuresh Kumar Balasubramanian, Asfar S Azmi, Jaroslaw Maciejewski
Wiley Interdisciplinary Reviews. RNA|May 17, 2021
microRNA-based diagnostic and therapeutic applications in cancer medicineLorenzo F Sempere, Asfar S Azmi, Anna Moore
Cancers|July 16, 2011
Small molecule inhibitors of bcl-2 family proteins for pancreatic cancer therapyAshiq Masood, Asfar S Azmi, Ramzi M Mohammad
Cancer Metastasis Reviews|May 28, 2013
Exosomes in cancer development, metastasis, and drug resistance: a comprehensive reviewAsfar S Azmi, Bin Bao, Fazlul H Sarkar
Pageof 16